News
  Pharming introduces Joenja in Japan for adult and paediatric patients with activated PI3K delta syndrome aged 4 and older,   August 14, 2026
  Tighter marketing codes encourages pharma sector to build on value-led engagement: Anindita Banik,   August 13, 2026
  Fresenius Kabi recalls one lot of Tyenne injection 400 mg/20 ml vials due to presence of glass particles,   August 12, 2026
  Innovent Biologics & Daiichi Sankyo enter agreement to commercialize Vanflyta in China,   August 11, 2026
  Zydus Lifesciences launches Revahale, India’s first once-daily nebulised LAMA for COPD,   August 10, 2026
  UK MHRA grants marketing authorization to Novartis Rhapsido for adult patients with CSU with inadequate response to H1 antihistamine,   August 08, 2026
  Adneuris grants exclusive license to Maruishi Pharma to advance cebranopadol in Japan and South Korea,   August 07, 2026
  Fresenius Kabi recalls one lot of Morphine sulfate injection USP in a simplist prefilled syringe due to labelling mix-up,   August 06, 2026
  Kaigene inks licensing agreement with Taisho Pharma for next-generation autoimmune asset ‘KG006’ in Japan,   August 01, 2026
  Lupin launches sugammadex injection in US following US FDA approval,   July 31, 2026
  European Commission grants marketing authorization for Pfizer and BioNTech XFG-adapted Covid-19 vaccine in European Union,   July 31, 2026
  Glenmark Pharmaceuticals launches sugammadex injection,   July 29, 2026
  Idorsia enters agreement with Jamjoom Pharma for distribution and commercialization of insomnia drug, Quviviq in Saudi Arabia and the Levant region,   July 28, 2026
  Sun Pharma partner Philogen re-submits Nidlegy application to EMA,   July 28, 2026
  EMA committee recommends marketing approval for Nezglyal to treat cALD, a rare neurodegenerative disease,   July 27, 2026
  Bristol Myers Squibb launches Relopduo for metastatic melanoma,   July 27, 2026
  Par Health introduces generic version of Janumet XR tablets in US,   July 27, 2026
  NewAmsterdam & Menarini receive positive CHMP opinion recommending marketing authorization for Ubeslo & Evlarco for patients with primary hypercholesterolemia,   July 27, 2026
  EMA recommends marketing authorization to Janssen-Cilag’s Icotyde to treat moderate-to-severe plaque psoriasis,   July 27, 2026
  JCR Pharma’s Izcargo, a blood-brain barrier-penetrating ERT for Hunter syndrome receives UAE marketing authorization,   July 23, 2026

Results Found: 7337

Go to Total Number of Pages: 367
 Back
Copyright © 2016 Saffron Media Pvt. Ltd |
counter